Actively Recruiting
Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis
Led by Boston Children's Hospital · Updated on 2026-04-27
600
Participants Needed
1
Research Sites
426 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.
CONDITIONS
Official Title
Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Seizure onset at less than 12 months of age
- Enrollment within 6 weeks of seizure-related presentation
- Patient at Boston Children's Hospital
- Parent of eligible infant (see above)
You will not qualify if you...
- Simple febrile seizures
- Acute provoked seizures such as those caused by sepsis, hemorrhage, electrolyte problems, cerebral infarction, hypoxic ischemic encephalopathy, or non-accidental injury
- Known genetic or acquired cause of epilepsy already identified, including brain MRI findings consistent with a specific genetic condition like tuberous sclerosis complex
- Deceased before enrollment
- Not the legal guardian of the eligible infant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
B
Beth R Sheidley, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here